The Cancer Quality Surveillance Programme is an integral part of the NHS Cancer Reform Strategy (2007). It supports the quality assurance and drives quality improvements in cancer services across England and Wales.
All the Multi-disciplinary Teams participate in the Cancer Quality Surveillance Programme. This is an Integrated Quality Assurance Programme for the NHS, led by The Quality Surveillance Team (QST). formerly National Peer Review Programme. Walsall is led by the Midlands and East regional team, who are involved in the surveillance and review visits of all specialised and cancer services.
The role of the QST is to improve the quality and outcomes of clinical services by delivering a sustainable and embedded quality assurance framework for all cancer services and specialised commissioned services within NHS England.
The programme has taken the best elements of the former National Peer Review Programme and other NHS functions to develop an integrated process for quality assurance which covers all aspects of quality in particular; patient safety, patient experience, clinical effectiveness and outcomes.
Health professionals if you require more information on the Cancer Quality Surveillance Programme please contact the Macmillan Lead Cancer Nurse, Lyn Waldron.